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A B S T R A C T
Background
Apnoea is a breathing disorder marked by the absence of airflow at the nose or mouth. In children, risk factors include adenotonsillar
hypertrophy, obesity, neuromuscular disorders and craniofacial anomalies. The most common treatment for obstructive sleep apnoea
syndrome (OSAS) in childhood is adeno-tonsillectomy. This approach is limited by its surgical risks, mostly in children with comorbidi-
ties and, in some patients, by recurrence that can be associated with craniofacial problems. Oral appliances and functional orthopaedic
appliances have been used for patients who have OSAS and craniofacial anomalies because they hold the lower jaw (mandible) forwards
which potentially enlarges the upper airway and increases the upper airspace, improving the respiratory function.
Objectives
To assess the effects of oral appliances or functional orthopaedic appliances for obstructive sleep apnoea in children.
Search methods
We searched the following electronic databases: Cochrane Oral Health’s Trials Register (to 7 April 2016); Cochrane Central Register
of Controlled Trials (CENTRAL; 2016, Issue 3) in the Cochrane Library (searched 7 April 2016); MEDLINE Ovid (1946 to 7 April
2016); Embase Ovid (1980 to 7 April 2016); LILACS BIREME (from 1982 to 7 April 2016); BBO BIREME (from 1986 to 7 April
2016) and SciELO Web of Science (from 1997 to 7 April 2016). We searched ClinicalTrials.gov and the World Health Organization
International Clinical Trials Registry Platform for ongoing trials on 7 April 2016. We placed no restrictions on the language or date of
publication when searching the electronic databases.
Selection criteria
All randomised or quasi-randomised controlled trials comparing all types of oral and functional orthopaedic appliances with placebo or
no treatment, in children 15 years old or younger. Primary outcome: reduction of apnoea to less than one episode per hour. Secondary
outcomes: dental and skeletal relationship, sleep parameters improvement, cognitive and phonoaudiological function, behavioural
problems, quality of life, side effects (tolerability) and economic evaluation.
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Data collection and analysis
Two review authors screened studies and extracted data independently. Authors were contacted for additional information.We calculated
risk ratios with 95% confidence intervals for all important dichotomous outcomes. We assessed the quality of the evidence of included
studies using GRADEpro software.
Main results
The initial search identified 686 trials. Only one trial, reporting the results from a total of 23 children and comparing an oral appliance to
no treatment, was suitable for inclusion in the review. The trial assessed apnoea-hypopnoea, daytime symptoms (sleepiness, irritability,
tiredness, school problems, morning headache, thirstiness in the morning, oral breathing and nasal stuffiness) and night-time symptoms
(habitual snoring, restless sleep and nightmares measured by questionnaire). Results were inconsistent across outcomes measures and
time points. The evidence was considered very low quality.
Authors’ conclusions
There is insufficient evidence to support or refute the effectiveness of oral appliances and functional orthopaedic appliances for the
treatment of obstructive sleep apnoea in children. Oral appliances or functional orthopaedic appliances may be considered in specified
cases as an auxiliary in the treatment of children who have craniofacial anomalies which are risk factors for apnoea.
P L A I N L A N G U A G E S U M M A R Y
Oral appliances and functional orthopaedic appliances for obstructive sleep apnoea in children
Review question
Are oral appliances and functional orthopaedic appliances effective and safe for treating childrenwith obstructive sleep apnoea syndrome?
Background
Obstructive sleep apnoea in children is a breathing disorder characterized by episodes of partial or complete upper airway obstruction
that occur during sleep. There are various risk factors and is associated with daytime and night-time symptoms including among
others sleepiness, irritability, tiredness, morning headaches, nasal stuffiness, habitual snoring, nightmares, etc. The common treatment
for obstructive sleep apnoea in childhood is adeno-tonsillectomy, the removal of the adenoids and tonsils. This approach is limited
by recurrence that can be associated with craniofacial problems. Oral/functional orthopaedic appliances have been used for patients
who have obstructive sleep apnoea and craniofacial anomalies because they hold the lower jaw (mandible) forwards which potentially
enlarges the upper airway and increases the upper airspace, improving the respiratory function.
Study characteristics
The evidence on which this review is based was current as of 7 April 2016. It included only one study in which 32 children were
randomised to receive an oral appliance or no treatment. Twenty-three participants finished the study.
Key results
Treatment of obstructive sleep apnoea syndrome in children appears to be possible with oral appliances or functional orthopaedic
appliances. However, this is only based on data from one small study.
Quality of the evidence
This was a study with a small number of participants and the quality of the evidence for the different outcomes was rated as very low.
At present there is insufficient evidence to conclude that oral or functional orthopaedic appliances are effective in the treatment of
obstructive sleep apnoea in children.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Oral appliance compared with no treatment for obstructive sleep apnoea in children
Patient or population: Children (age range 4 to 10 years old)
Setting:
Intervention: Oral appliance
Comparison: No treatment
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with no treatment Risk with oral appli-
ance
Apnoea-hypopnoea in-
dex (AHI)
assessed with
polysomnography
Follow-up: 6 months
Study populat ion RR 0.39
(0.20 to 0.76)
23
(1 RCT)
⊕©©©
VERY LOW 123
1.000 per 1.000 390 per 1.000
(200 to 760)
Dayt ime symptoms:
Sleepiness
as-
sessed with Brouillet te
quest ionnaire (consid-
ered improvement a fall
of at least 2 points in
the score)
Follow-up: 6 months
Study populat ion RR 0.64
(0.11 to 3.78)
23
(1 RCT)
⊕©©©
VERY LOW 123
Change measured with
a subject ive quest ion-
naire answered by par-
ents
222 per 1.000 142 per 1.000
(24 to 840)
Dayt ime symptoms: Ir-
ritability
as-
sessed with Brouillet te
quest ionnaire (consid-
ered improvement a fall
of at least 2 points in
Study populat ion RR 0.32
(0.07 to 1.41)
23
(1 RCT)
⊕©©©
VERY LOW 123
Change measured with
a subject ive quest ion-
naire answered by par-
ents
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the score)
Follow-up: 6 months
444 per 1.000 142 per 1.000
(31 to 627)
Dayt ime symptoms:
Tiredness
as-
sessed with Brouillet te
quest ionnaire (consid-
ered improvement a fall
of at least 2 points in
the score)
Follow-up: 6 months
Study populat ion RR 0.26
(0.06 to 1.05)
23
(1 RCT)
⊕©©©
VERY LOW 123
Change measured with
a subject ive quest ion-
naire answered by par-
ents
556 per 1.000 144 per 1.000
(33 to 583)
Dayt ime symptoms:
School problems
as-
sessed with Brouillet te
quest ionnaire (consid-
ered improvement a fall
of at least 2 points in
the score)
Follow-up: 6 months
Study populat ion RR 0.64
(0.11 to 3.78)
23
(1 RCT)
⊕©©©
VERY LOW 123
Change measured with
a subject ive quest ion-
naire answered by par-
ents
222 per 1.000 142 per 1.000
(24 to 840)
Dayt ime symptoms:
Morning headache
as-
sessed with Brouillet te
quest ionnaire (consid-
ered improvement a fall
of at least 2 points in
the score)
Follow-up: 6 months
Study populat ion RR 0.39
(0.12 to 1.23)
23
(1 RCT)
⊕©©©
VERY LOW 123
Change measured with
a subject ive quest ion-
naire answered by par-
ents
4
O
ra
l
a
p
p
lia
n
c
e
s
a
n
d
fu
n
c
tio
n
a
l
o
rth
o
p
a
e
d
ic
a
p
p
lia
n
c
e
s
fo
r
o
b
stru
c
tiv
e
sle
e
p
a
p
n
o
e
a
in
c
h
ild
re
n
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
6
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
556 per 1.000 217 per 1.000
(67 to 683)
Dayt ime symptoms:
Oral breathing
as-
sessed with Brouillet te
quest ionnaire (consid-
ered improvement a fall
of at least 2 points in
the score)
Follow-up: 6 months
Study populat ion RR 0.16
(0.04 to 0.59)
23
(1 RCT)
⊕©©©
VERY LOW 123
Change measured with
a subject ive quest ion-
naire answered by par-
ents
889 per 1.000 142 per 1.000
(36 to 524)
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI)
CI: Conf idence interval; RR: Risk rat io; RCT: Randomised controlled trial
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Quasi-randomised study, no allocat ion concealment, no blinding, attrit ion bias (overall high risk of bias).
2 Low sample size and wide conf idence interval (imprecision).
3 Single, small study (may lack generalisability).
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B A C K G R O U N D
Description of the condition
Apnoea is a breathing disorder marked by the absence of airflow
through the nose or mouth. It is divided into central, obstructive
and mixed apnoea. In central apnoea, airflow is absent due to the
lack of respiratory efforts. In obstructive apnoea, airflow is absent,
in spite of continuing respiratory efforts, due to the obstruction of
the upper airway. In mixed apnoea, central and obstructive apnoea
occurs sequentially with no normal breathing between the two
events (Carroll 1995a).
Sleep disordered breathing is common in childhood (Nixon 2005;
Schechter 2002). It occurs in children of all ages, from neonates
to adolescents (Marcus 2001). It is estimated that 0.8% to 24% of
children are habitual snorers and that 1% to 5% have obstructive
sleep apnoea syndrome (OSAS) (Marcus 2012). OSAS in chil-
dren is characterized by episodes of partial or complete upper air-
way obstruction that occur during sleep, usually associated with
a reduction in oxyhaemoglobin saturation or hypercarbia or both
(Carroll 1995a).
The aetiology is multifactorial. OSAS arises when the balance be-
tween the factors maintaining airway patency and those promot-
ing airway collapse is perturbed. This balance is determined by
the interactions of central ventilatory responses to hypoxia, hyper-
capnia and airway occlusion, upper-airway neuromuscular tone,
the effects of sleep state and arousal, and the anatomic size and
resistance of the upper airway (Ward 1996).
In children, risk factors include obesity, adenotonsillar hypertro-
phy, neuromuscular disorders and craniofacial anomalies (AAP
Guideline 2002; Kohler 2008; Shintani 1998). These factors can
reduce the volume of the oronasopharyngeal cavity and can result
in the tongue falling into the oropharynx (Viva 1992). There are
many malocclusions associated with obstructive sleep apnoea, e.g.
retrognathism/micrognathias, unilateral or bilateral cross bite, and
open bite (Carvalho 2014; Defabjanis 2003).
OSAS in children is associated with a series of daytime and night-
time signs and symptoms. The daytime symptoms include exces-
sive daytime sleepiness and abnormal daytime behaviour ranging
from aggressiveness and hyperactivity to pathological shyness and
social withdrawal, morning headaches and frequent upper airway
infections. Nocturnal symptoms include difficult breathing whilst
asleep, heavy snoring, apnoeic episodes, restless sleep, heavy sweat-
ing, nightmares, night terrors and enuresis (Guilleminault 1990).
Untreated obstructive sleep apnoea syndrome can result in serious
morbidity. Early reports documented such complications as failure
to thrive (Bell 2001), cor pulmonale and neurological dysfunction
(Brouillette 1982), and other reports have suggested that children
with OSAS have neurocognitive deficits (Goldstein 2000), such as
poor learning, behavioural problems (Bell 2001), attention deficit
hyperactivity disorder (AAP Guideline 2002; Chervin 1997) and
systemic inflammation (Kheirandish-Gozal 2006). However, the
symptoms can be very varied and difficult to detect (Carroll 2003).
Diagnosis of OSAS may be based on information obtained
by clinical history, physical examination and laboratory studies
(Carroll 1995b). The ’gold standard’ for the diagnosis of OSAS
is polysomnography (AAP Guideline 2002; Schechter 2002),
which is made up of channels for electrocardiography (ECG),
electroencephalography (EEG), electroculography (EOG), elec-
tromyography (EMG), nasal and oral airflow, chest and abdomi-
nal movements, pulse oximetry arterial oxygen saturation (SpO2)
and end tidal carbon dioxide tension (PETCO2) (Uliel 2004).
Polysomnography provides information on a number of sleep-re-
lated parameters: number and duration of complete or partial ob-
structions per hour of sleep, lowest oxygen saturation during each
event, time spent below a given level of oxygen saturation during
the night, presence and type of cardiac arrhythmias, and presence
and severity of respiratory disturbances and their impact on the
cardiovascular system. It also provides information on the severity
of sleep disruption (Guilleminault 1990).
Treatment for OSAS must be based on the assessment, duration
and severity of symptoms and the anatomic structural and physio-
logical abnormalities and their associated severity (Carroll 1995b).
There are several treatments for OSAS in childhood, like alter-
ation of the sleeping position, continuous positive airways pressure
(CPAP), weight loss (AAP Guideline 2002), tracheostomy, max-
illomandibular advancement (Bell 2001), uvulopalatopharyngo-
plasty, oral appliances and adeno-tonsillectomy (AAP Guideline
2002; Schechter 2002).
The most common treatment for obstructive sleep apnoea syn-
drome in childhood is adeno-tonsillectomy, but this approach is
limited by its surgical risks (Chan 2004). In some patients there is
recurrence of the OSA especially in those with underlying skeletal
deformities e.g. retrognathic mandible or constricted maxilla or
both (Guilleminault 1989). Children who do not improve after
adeno-tonsillectomy tend to have a narrower epipharyngeal air
space, a more poorly developed maxilla and mandibular retrusion
(Shintani 1998).
Description of the intervention
Functional orthopaedic appliances are usually removable intraoral
devices which alter the muscle forces against the teeth and facial
skeleton i.e. maxilla and mandible. These are dynamic appliances
which depend on altered neuromuscular action to affect bony
growth and occlusal development.
How the intervention might work
Functional orthopaedic appliances have been used for patients
who haveOSAS and craniofacial anomalies because functional or-
thopaedic appliances posture the mandible forwards and poten-
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tially enlarge the upper airway and increase the upper airspace,
improving the respiratory function (Defabjanis 2003; Viva 1992).
Why it is important to do this review
OSAS in children has been shown to be a prevalent condition and
also a disease that can cause a number of other medical and/or
social problems if left untreated. Many adults’ OSAS started in
childhood or adolescence so the importance of recognizing OSAS
in childhood and the need for appropriate treatment should be em-
phasized to avoid potential long-term complications in adulthood.
If the problem is recognized and treated early, there is a potential
to reduce the economic costs to the health system (Tarasiuk 2007)
and improve the quality of life for sufferers (Nixon 2005). This
review updates the previous version published in 2007 (Carvalho
2007).
O B J E C T I V E S
To assess the effects of oral appliances or functional orthopaedic
appliances for obstructive sleep apnoea in children.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We aimed to identify all randomised controlled trials (RCTs). Tri-
als using quasi-random methods of allocation (such as alternation,
date of birth, record number) were included and would have been
subjected to a sensitivity analysis.
Types of participants
Children and adolescents. We included trials in which over 80%
of included participants were 15 years old or younger, receiving
oral appliances or functional orthopaedic appliances to treat ob-
structive sleep apnoea. Criteria for abnormal values for obstruc-
tive apnoea in children considered as one or more apnoea, of any
length, per hour of sleep, measured by standard polysomnography
(Marcus 1992). Trials including patients with a cleft lip or palate
or both were excluded. There was no gender restriction.
Types of interventions
Intervention group: All types of oral and functional appliances
used to treat obstructive sleep apnoea were compared to placebo
or no treatment. Several types of appliances are used for this sit-
uation including: Bimler appliance, Frankel appliance, Harvold
appliance, Andresen appliance, Bionator, bite block, Herbst ap-
pliance, Herren activator and Woodside activator.
Control group: Placebo or no treatment.
We excluded trials including other interventions like continu-
ous positive airways pressure (CPAP), weight loss (dietary inter-
vention), lifestylemodification, tracheostomy, maxillomandibular
surgery, uvulopalatopharyngoplasty and adeno-tonsillectomy.
Types of outcome measures
Primary outcomes
1. Reduction to less than one episode of apnoea per hour
measured by standard polysomnography.
Secondary outcomes
1. Reduction of apnoea episodes measured by standard
polysomnography.
2. Reduction of upper airway resistance syndrome (UARS)
measured by standard polysomnography and body-weight
development curve compared by graphic of body mass index for
age percentiles.
3. Reduction of snoring measured by standard
polysomnography.
4. Signs and symptoms of respiratory disease: mouth
breathing, nasal airway resistance measured by clinical
assessment or rhinomanometry or fibroscopy.
5. Signs and symptoms of atypical swallowing, and speech
production disturbance measured by validated tests for speech
production or videofluoroscopy or clinical assessment.
6. Daytime and nocturnal symptoms e.g. daytime sleepiness,
behavioural problems, nightmares.
7. Change of mandibular length measured by cephalometric
data.
8. Improvement on sagittal relationship between the maxilla-
mandible measured by cephalometric data.
9. Changes of the width between cuspids and first molars
measured by plaster models.
10. Change of the arch perimeter measured by plaster models.
11. Improvement of the overbite and overjet measured by
plaster models.
12. Alteration of growth pattern measured in cephalometric
data or facial analysis.
13. Quality of life measured by validated scale.
14. Side effects - tolerability - measured by patient’s self report.
15. Economic evaluation - costs.
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16. Educational outcomes: cognitive function measured by
validated scale.
Search methods for identification of studies
To identify studies for this review, we developed detailed search
strategies for each database searched. These were based on the
search strategy developed for MEDLINE (Ovid) but revised ap-
propriately for each database. The search strategy used a combina-
tion of controlled vocabulary and free text terms and was linked
with the Cochrane Highly Sensitive Search Strategy (CHSSS)
for identifying randomised trials (RCTs) in MEDLINE: sensi-
tivity maximising version (2008 revision) as referenced in Chap-
ter 6.4.11.1 and detailed in box 6.4.c of the Cochrane Hand-
book for Systematic Reviews of Interventions Version 5.1.0 (up-
dated March 2011) (Higgins 2011). Details of the MEDLINE
search are provided in Appendix 1. The Embase subject search
was linked to an adapted version of the Cochrane Embase
Project filter for identifying RCTs in Embase via Ovid (see http:/
/www.cochranelibrary.com/help/central-creation-details.html for
information). Searches of LILACs and BBO were linked to the
Brazilian Cochrane Center filter for identifying RCTs.
Electronic searches
We searched the following electronic databases:
• Cochrane Oral Health’s Trials Register (searched 7 April
2016) (Appendix 2);
• Cochrane Central Register of Controlled Trials
(CENTRAL; 2016, Issue 3) in the Cochrane Library (searched 7
April 2016) (Appendix 3);
• MEDLINE Ovid (1946 to 7 April 2016) (Appendix 1);
• Embase Ovid (1980 to 7 April 2016) (Appendix 4);
• LILACS BIREME Virtual Health Library (Latin American
and Caribbean Health Science Information database; from 1982
to 7 April 2016) (Appendix 5);
• BBO BIREME Virtual Health Library (Bibliografia
Brasileira de Odontologia; from 1986 to 7 April 2016)
(Appendix 5);
• SciELO Web of Science (from 1997 to 7 April 2016)
(Appendix 6).
No restrictions were placed on the language or date of publication
when searching the electronic databases.
Searching other resources
We searched the following trial registries for ongoing studies:
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (www.clinicaltrials.gov; searched 7 April 2016)
(Appendix 7);
• World Health Organization International Clinical Trials
Registry Platform (apps.who.int/trialsearch; searched 7 April
2016) (Appendix 8).
References from original papers and review articles were cross-
checked to identify additional trials and no further randomised
controlled trials were found.
We contacted first authors of randomised controlled trials and spe-
cialists to identify further information about unpublished studies.
Data collection and analysis
Selection of studies
Four review authors (Fernando Rodrigues Carvalho (FRC), Deb-
ora Lentini-Oliveira (DLO), Lucila Fernandes Prado (LFP), and
Gilmar Fernandes Prado (GFP)) scanned the titles and abstracts
of all reports identified through the searches. Full reports were
obtained for trials appearing to meet the inclusion criteria or for
which there was insufficient information in the title and abstract
to make a clear decision. Full reports obtained were assessed inde-
pendently, in duplicate, by two review authors (FRC and DLO)
to establish whether the trials met the inclusion criteria or not.
Disagreements were resolved by discussion with the main super-
visor (Luciane Bizari Carvalho (LBC)).
Data extraction and management
Two review authors (FRC andDLO) extracted data independently
using specially designed data extraction forms. The date of the
study, year of publication, setting and funding source of trials,
sample size, age (mean or range, or both) and gender of partic-
ipants, types of interventions, duration of study and tolerability
were recorded.
The characteristics of the trial participants, interventions and out-
comes for the included trial are presented in the Characteristics of
included studies table.
We contacted study authors for clarification or for further infor-
mation.
Assessment of risk of bias in included studies
The quality assessment of the included trial was undertaken inde-
pendently and in duplicate by two review authors (FRC andDLO)
as part of the data extraction process. If there was uncertainty, the
main supervisor (LBC) was consulted.
We used Cochrane’s tool for assessing risk of bias as outlined in the
Cochrane Handbook for Systematic Reviews of Interventions Version
5.1.0 (updated March 2011) (Higgins 2011).
We examined seven domains:
1. sequence generation,
2. allocation sequence concealment,
3. blinding of participants/personnel,
4. blinding of outcome assessment,
5. incomplete outcome data,
6. selective outcome reporting,
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7. other bias (balance of baseline characteristics, free from co-
intervention).
Each domain included one or more specific entries in a ’Risk of
bias’ table. Within each entry, we described information reported
in the study and assigned a judgement relating to the risk of bias
for that entry. Where the study clearly reported the methodology,
wemade a judgement of low risk of bias or high risk of bias. Where
trial methodology was unclear, we judged a domain as at unclear
risk of bias. We tried to get more information from the study
authors. When we were provided with additional information, we
re-assessed the overall risk of bias in included trials over all seven
domains.
We categorised the overall risk of bias of individual studies accord-
ing to the following criteria:
• low risk of bias (plausible bias unlikely to seriously alter the
results; all seven domains assessed as at low risk of bias),
• high risk of bias (plausible bias that seriously weakens
confidence in the results; at least one domain assessed as at high
risk of bias),
• unclear risk of bias (plausible bias that raises some doubt
about the results; at least one domain assessed as at unclear risk
of bias, but none at high risk of bias).
We also presented the risk of bias summary graphically (Figure 1).
Figure 1. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Measures of treatment effect
We calculated risk ratios, the number needed to treat and cor-
responding 95% confidence intervals for dichotomous data and
expressed them by individual study. In cases where the included
studies presented results as continuous data, we would have ex-
pressed the results as mean difference and 95% confidence inter-
vals. For both continuous and dichotomous data we would have
carried out a meta-analysis when possible and appropriate.
Unit of analysis issues
Trials with multiple treatment arms: For trials with more than one
intervention group and a common control group (placebo or no
intervention) we would have tried to use the partial data, only data
from relevant group and control group.
Cross-over studies were not felt to be an appropriate study design
for this research question due to potential carry over effects of the
first treatment.
Dealing with missing data
We attempted to contact the author(s) of included studies, where
feasible, for clarification, missing data, and details of any other
outcomes that may have been measured but not reported.
Assessment of heterogeneity
The significance of discrepancies in the estimates of treatment ef-
fects from the different trials would have been assessed by the I
2 statistic and classified according to the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). A guide to in-
terpretation of the I2 statistic is as follows:
• 0% to 40% might not be important,
• 30% to 60% may represent moderate heterogeneity,
• 50% to 90% may represent substantial heterogeneity,
• 75% to 100% very substantial (considerable) heterogeneity.
Assessment of reporting biases
Within-study reporting bias, it is one of the seven domains of the
Risk of bias as ’selective outcome reporting’. It would ideally be
assessed by comparing the outcomes in the paper published against
the study protocol. As it is not possible in most cases, we compared
the outcomes referred in the methods with the results showed.
If the outcome were listed in the methods but not reported, we
try to get more information from authors of the study, then we
judge this as ’high risk’ or ’low risk’ of bias or ’unclear’ (insufficient
information to judge the risk of bias).
If possible, publication bias would have been assessed by plotting
data onto a funnel graph (trial effect versus trial size) (Egger 1997).
However, this was not feasible due to the inclusion of only one
study.
Data synthesis
For the included trial, risk ratios with 95% confidence intervals
were calculated for all important dichotomous outcomes.
If further studies are included in future updates, we will carry out
meta-analyses where there are studies of similar comparisons re-
porting the same outcomes. We would combine mean differences
for continuous data, and risk ratios for dichotomous data. Our
general approach would be to use a random-effects model. With
this approach, the CIs for the average intervention effect would
be wider than those that would be obtained using a fixed-effect
approach, leading to a more conservative interpretation.
We would use additional tables to report the results from studies
not suitable for inclusion in a meta-analysis.
Subgroup analysis and investigation of heterogeneity
A subgroup analysis would have been carried out comparing stud-
ies that included different ranges of participants’ age, but there
were insufficient trials to undertake this.
Sensitivity analysis
Sensitivity analyses would have been performed according to the
risk of bias assessments of the included studies. If there had been
an adequate number of studies, quasi-randomised studies would
also have been analysed separately from the randomised ones in a
sensitivity analysis. However, as there was only one study included
in the review, no sensitivity analyses were carried out.
Presentation of main results
We established a ’Summary of findings’ table using the following
outcomes listed according to priority.
1. Apnoea-hypopnoea index (AHI) (assessed with
polysomnography).
2. Daytime symptoms: sleepiness (assessed with Brouillette
questionnaire).
3. Daytime symptoms: irritability (assessed with Brouillette
questionnaire).
4. Daytime symptoms: tiredness (assessed with Brouillette
questionnaire).
5. Daytime symptoms: school problems (assessed with
Brouillette questionnaire).
6. Daytime symptoms: morning headache (assessed with
Brouillette questionnaire).
7. Daytime symptoms: oral breathing (assessed with
Brouillette questionnaire).
R E S U L T S
Description of studies
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Results of the search
We identified a total of 686 potentially relevant records by elec-
tronic searching. Six hundred and seventy-nine records were dis-
carded as not relevant for this review after assessment of the ti-
tles and abstracts. After obtaining the full texts, we excluded three
studies (five records) (Ghodke 2014; Guilleminault 2011; Nunes
2011) and included one study (two records) (Villa 2002). We are
not aware of any ongoing study.
We used the full search conducted as described in the Search
methods for identification of studies section on 7 April 2016 to
construct the PRISMA flow chart shown as Figure 2.
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Figure 2. Study flow diagram, 2016 search.
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Summary details are given in the Characteristics of included
studies and Characteristics of excluded studies tables.
Included studies
Villa 2002 is a quasi-randomised controlled trial conducted in Italy
during six months. Randomisation was assigned alphabetically, by
surname.
Thirty-two children, 20 male and 12 female, with an age range of
4 to 10 years (mean 7.1 +/- 2.6 years), with apnoea index (defined
as the number of apnoeas per hour of total sleep time) of more
than one event per hour diagnosed by polysomnography and who
had evident clinical signs of dysgnathia participated in this study.
Villa 2002 compared a personalised active oral appliance to no
treatment. Email correspondence with the study authors con-
firmed that the participants were fitted the oral appliance at the
time of the second polysomnography.
The parents of all participants completed amodified version of the
Brouillette questionnaire on the daytime and night-time symp-
toms before the trial and after six months. The answers of the
questionnaire range from 0 to 4 points and they were considered
an improvement when the answers fell at least two points, after six
months.
The outcomes measured included apnoea-hypopnoea index mea-
sured by polysomnography; daytime symptoms: sleepiness, irri-
tability, tiredness, school problems, morning headache, thirstiness
in the morning, oral breathing and nasal stuffiness measured by
questionnaire; and night-time symptoms: habitual snoring, rest-
less sleep and nightmares measured by questionnaire.
Excluded studies
Three studies did not meet the inclusion criteria and they were
excluded. The main reasons for exclusion were:
• polysomnography not used to evaluate sleep (two studies),
• study compared an oral appliance to surgery without
placebo or no treatment group (one study).
Risk of bias in included studies
Allocation
Sequence generation
The included trial (Villa 2002) used a quasi-random method of
allocation, alphabetically by surname, and was assessed at high risk
of selection bias.
Allocation concealment
Villa 2002 did not report any information about allocation con-
cealment, but the poor randomisation method used would have
made adequate allocation concealment impossible in this trial. It
was therefore assessed at high risk of bias for this domain.
Blinding
In Villa 2002 it was impossible to blind the participants because
the intervention group wore an oral appliance whilst the control or
no treatment groupwore nothing and could easily be distinguished
from the active intervention. We assessed the study at high risk of
performance bias.
Blinding of outcome assessment was not reported, therefore we
assessed the study at unclear risk of detection bias.
Incomplete outcome data
We assessed Villa 2002 at high risk of attrition bias due to the high
percentage of participants lost to follow-up: five (26.3%) partic-
ipants in the treatment group and four (30.8%) participants in
the control group. The reasons for dropouts within the treatment
group were described: one child found the oral appliance intoler-
able, two children lost their appliances three times and then re-
fused to wear them again and two children found wearing the oral
appliance at school embarrassing and discontinued therapy.
Selective reporting
Ideally we would have compared the outcomes listed in each study
protocol with the outcomes reported in the papers, but since this
was impossible, we then compared the results reported in the in-
cluded study against those listed in the methods section. We as-
sessed Villa 2002 at low risk of reporting bias, because the out-
comes reported in the results section were all those listed in the
methods.
Other potential sources of bias
Balance of baseline characteristics and free from co-
intervention
The study authors reported that there were no differences between
groups at baseline but there is no analysis to support this. The
study authors did not report any other interventions during the
same treatment time. We therefore assessed the included study at
unclear risk of other bias.
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Overall risk of bias
A summary of the risk of bias assessments for each domain is shown
in Figure 1 . The included trial in this review was assessed at high
risk of bias.
Effects of interventions
See: Summary of findings for the main comparison
Meta-analyses were originally planned, but they were not possible
since only one study was included (Villa 2002).
It has not been possible to fully achieve the objectives of this re-
view as there is a lack of trials in this area. The included trial (Villa
2002) compared a personalised active oral appliance to no treat-
ment and helped us to answer four secondary outcomes: reduction
of apnoea episodes measured by standard polysomnography; day-
time and nocturnal symptoms e.g. daytime sleepiness, behavioural
problems, nightmares and side effects - tolerability - measured by
patient’s self report.
We calculated risk ratios (RRs) with 95% confidence intervals
(CIs) for all dichotomous data as planned.
We found statistically significant differences in the following re-
sults: reduction of the apnoea-hypopnoea index measured by
polysomnography; daytime symptomsmeasured by questionnaire:
oral breathing and nasal stuffiness; and night-time symptomsmea-
sured by questionnaire: habitual snoring and restless sleep.
All outcomes and results are described below.
Primary outcomes
Reduction to less than one episode of apnoea per hour
measured by standard polysomnography
A decrease of at least 50% in the apnoea/hypopnoea index (AHI)
was considered in this study (Villa 2002) as treatment success. In
9 of the 14 treated subjects (62.4%) the AHI fell 50%. Villa 2002
showed the apnoea index only in the oral appliance group before
(7.1 +/- 4.6) and after (2.6 +/- 2.2) the treatment as mean values
and standard deviation. It proved impossible to know how many
patients had apnoea index < 1 (primary outcome).
Secondary outcomes
(1) Reduction of apnoea episodes measured by standard
polysomnography
Results from the paper can be found in Additional Table 1.
Results from our analysis: RR = 0.39, 95% CI 0.20 to 0.76, P
= 0.006, favouring treatment (Analysis 1.1), but result is from a
studywith very lowquality of evidence for this outcome (Summary
of findings for the main comparison).
(2) Reduction of upper airway resistance syndrome (UARS)
measured by standard polysomnography and body-weight
development curve compared by graphic of body mass index
for age percentiles
The included study did not assess this outcome.
(3) Reduction of snoring measured by standard
polysomnography
The included study did not assess this outcome.
(4) Signs and symptoms of respiratory disease: mouth
breathing, nasal airway resistance measured by clinical
assessment or rhinomanometry or fibroscopy
The included study did not assess this outcome.
(5) Signs and symptoms of atypical swallowing, and speech
production disturbance measured by validated tests for
speech production or videofluoroscopy or clinical
assessment
The included study did not assess this outcome.
(6) Daytime and nocturnal symptoms
Daytime symptoms (measured by questionnaire)
Results from the paper are presented in Additional Table 2 and
Table 3.
Results from our analysis.
• Sleepiness: RR = 0.64, 95% CI 0.11 to 3.78 (Analysis 1.2),
non-significant result (Summary of findings for the main
comparison).
• Irritability: RR = 0.32, 95% CI 0.07 to 1.41 (Analysis 1.3),
non-significant result (Summary of findings for the main
comparison).
• Tiredness: RR = 0.26, 95% CI 0.06 to 1.05 (Analysis 1.4),
non-significant result (Summary of findings for the main
comparison).
• School problems: RR = 0.64, 95% CI 0.11 to 3.78
(Analysis 1.5), non-significant result (Summary of findings for
the main comparison).
• Morning headache: RR = 0.39, 95% CI 0.12 to 1.23
(Analysis 1.6), non-significant result (Summary of findings for
the main comparison).
• Thirsty in the morning: RR = 0.16, 95% CI 0.02 to 1.22
(Analysis 1.7), non-significant result.
• Oral breathing: RR = 0.16, 95% CI 0.04 to 0.59, P = 0.006
(Analysis 1.8), favouring treatment, but result is from a study
with very low quality of evidence for this outcome (Summary of
findings for the main comparison).
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• Nasal stuffiness: RR = 0.18, 95% CI 0.05 to 0.69, P = 0.01
(Analysis 1.9), favouring treatment, but result is from a study
with very low quality of evidence.
Nocturnal symptoms (measured by questionnaire)
Results from the paper are presented in Additional Table 4 and
Table 5.
Results from our analysis.
• Habitual snoring: RR = 0.18, 95% CI 0.06 to 0.55, P =
0.003 (Analysis 1.10), favouring treatment, but result is from a
study with very low quality of evidence.
• Restless sleep: RR = 0.21, 95% CI 0.05 to 0.84, P = 0.03
(Analysis 1.11), favouring treatment, but result is from a study
with very low quality of evidence.
• Nightmares: RR = 0.22, 95% CI 0.01 to 4.93 (Analysis
1.12), non-significant result.
(7) Change of mandibular length measured by
cephalometric data
The included study did not assess this outcome.
(8) Improvement on sagittal relationship between the
maxilla-mandible measured by cephalometric data
The included study did not assess this outcome.
(9) Changes of the width between cuspids and first molars
measured by plaster models
The included study did not assess this outcome.
(10) Change of the arch perimeter measured by plaster
models
The included study did not assess this outcome.
(11) Improvement of the overbite and overjet measured by
plaster models
The included study did not assess this outcome.
(12) Alteration of growth pattern measured in
cephalometric data or facial analysis
The included study did not assess this outcome.
(13) Quality of life measured by validated scale
The included study did not assess this outcome.
(14) Side effects - tolerability - measured by patient’s self
report
Side effects: the included study did not assess this outcome.
Tolerability: 73.7% fitted with oral appliance (14/19 children) tol-
erated the treatment well and 26.3% (five children) discontinued
therapy (two preferred not to wear the oral appliance, two lost
their appliances three times and then refused to wear them again
and one did not tolerate it).
(15) Economic evaluation - costs
The included study did not assess this outcome.
(16) Educational outcomes: cognitive function measured by
validated scale
The included study did not assess this outcome.
D I S C U S S I O N
Summary of main results
The main aim of this review was to estimate the effects of the use
of oral appliances or functional appliances for treating obstructive
sleep apnoea in children compared to placebo or no treatment.We
found no new studies for inclusion in this update, so Villa 2002
remains as the only included study in the review.
Villa 2002 compared an oral appliance to no treatment and pre-
sented results analysing each group before and after six months
follow-up. It found favourable results in the treated group for ap-
noea/hypopnoea index, night-time symptoms (habitual snoring,
restless sleep) and daytime symptoms (sleepiness, irritability, tired-
ness, thirstiness in the morning, oral breathing, nasal stuffiness)
(Additional Table 1; Table 2; Table 3; Table 4; Table 5). When
we compared the two groups at six months, the results were not
as favourable as those presented in the original study. We found
favourable results in the treated group for apnoea/hypopnoea in-
dex, night-time symptoms (habitual snoring, restless sleep) and
daytime symptoms (oral breathing, nasal stuffiness) (Analysis 1.1;
Analysis 1.2; Analysis 1.3; Analysis 1.4; Analysis 1.5; Analysis 1.6;
Analysis 1.7; Analysis 1.8; Analysis 1.9; Analysis 1.10; Analysis
1.11; Analysis 1.12).
Overall completeness and applicability of
evidence
Unfortunately, the available information from one study (Villa
2002) with very low quality of evidence, is not enough to answer
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whether oral appliances or functional orthopaedic appliances are
effective in the treatment of sleep apnoea in children.
Quality of the evidence
Villa 2002 was the single study included and although it showed
some results that favoured the intervention, it must be considered
with caution due to methodological problems such as a non-ran-
domised generation of allocation, no allocation concealment, no
blinding, no sample size calculation reported, the number of pa-
tients randomised was different from patients analysed, high num-
ber of losses to follow-up and no intention-to-treat analysis. Villa
2002 was therefore assessed as at high risk of bias and of very low-
quality evidence (Summary of findings for the main comparison).
There is an important methodological problem we found with
many studies not showing important information necessary to
assess their quality. Papers did not present information such as
how participants were allocated to interventions, who generated
the allocation, how sample size was determined, etc. Therefore it
is important that all authors follow the Consolidated Standards
of Reporting Trials (CONSORT) guidelines when designing and
reporting trials (Begg 1996; Moher 2001).
Potential biases in the review process
We conducted a sensitive search strategy of multiple databases to
identify suitable studies for this review, with no restrictions on
language, publication status, date or source of information. We
attempted to contact some study authors for missing information,
however, we could not find more studies, and some authors did
not respond. We could not get all the necessary information to
clarify our judgements of unclear or high risk of bias. Therefore,
authors of the included study are encouraged to contact us to
clarify these points. For future updates, we would also appreciate
any information regarding unpublished or ongoing studies that
we may not have identified.
Agreements and disagreements with other
studies or reviews
The aim of this systematic review was to assess the effects of oral
appliances and functional orthopaedic appliances in the treatment
of obstructive sleep apnoea in children when compared to placebo
or no treatment. There is a clinical trial (Guilleminault 2008)
whose participants were children with adenotonsillar hypertrophy
and malocclusion that concluded that for most of the children,
the two proposed treatments were needed (intraoral appliance and
adeno-tonsillectomy) independently of which treatment was done
first, but one treatment would complement the other in resolving
obstructive sleep apnoea.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Despite a thorough search for evidence relating to the effects of
treatment with oral appliances or functional orthopaedic appli-
ances for obstructive sleep apnoea in children, very low-quality
evidence was found, but it must be interpreted as ’very low evi-
dence of effect’ and not as ’evidence of very low effect’. At present
there is not enough evidence to affirm that oral appliances and
functional orthopaedic appliances are effective in the treatment
of obstructive sleep apnoea in children. Oral appliances or func-
tional orthopaedic appliances may be considered in specified cases
as an auxiliary in the treatment of children who have craniofacial
anomalies which are risk factors for apnoea.
Implications for research
We suggest that clinical trials on malocclusion problems or respi-
ratory disease should include information and results about how
to improve respiratory and malocclusion problems. It is impor-
tant that dentists look for any respiratory problems when treating
a malocclusion because they can be treating respiratory problems
without knowing, or when they diminish the oral space they can
be promoting the tongue to fall into the oropharynx and cause
obstructive sleep apnoea, or they can face difficulties when treating
some malocclusion because there is a respiratory problem associ-
ated. It is also important that physicians treating respiratory prob-
lems look for malocclusion problems, because some respiratory
problems can return if the malocclusion problem is not solved.
Clinical trials must have well established the objective of the re-
search. It will be make a difference when the results are interpreted.
If the objective is only a palliative or immediate care to dimin-
ish the apnoea index, the oral appliance can be indicated because
it will change the mandibular position forwards and enlarge the
upper airway space. The polysomnography to assess the results
can be made after a short period of time that the oral appliance
has been fitted, and at the moment of the polysomnography the
oral appliance must be in the mouth. But if the objective is to
treat and cure with the use of the oral appliance that not only will
change the mandibular position forwards and enlarge the upper
airway but also promote dento-alveolar and skeletal growth, the
polysomnography to assess the results must be made after a longer
period of time and the oral appliance must not be in the mouth.
Good quality randomised controlled trials that involve a represen-
tative number of patients with apnoea andmalocclusion are neces-
sary to answer the principal question of this systematic review: are
oral appliances or functional orthopaedic appliances an effective
treatment for obstructive sleep apnoea in children.
Reporting of clinical trials could be improved adopting the Con-
solidated Standards of Reporting Trials (CONSORT) statement
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(Begg 1996; Moher 2001) to ensure that all relevant information
is provided.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Villa 2002
Methods Trial design: Quasi-randomised, unblinded, prospective study
Location: Italy
Duration: 6 months
Participants Inclusion criteria: Apnoea index of > 1 event/hour of sleep and dysgnathia (87% partic-
ipants with deep and retrusive bite and 13% with cross-bite: 86% had deep and retru-
sive bite and 14% had cross-bite in treated group; 100% had deep and retrusive bite in
control group)
Gender: 20 male, 12 female
Age range: 4 to 10 years
Number randomised: 32 (Group 1 = 19; Group 2 = 13)
Number evaluated: 23 (Group 1 = 14; Group 2 = 9).
Dropouts: Group 1 = 5 (2 claimed that they lost their appliances 3 times and then refused
to wear them again, 2 children found wearing the oral appliance at school embarrassing
and discontinued therapy, and 1 child found the oral appliance intolerable because
putting it into the mouth triggered violent, uncontrollable coughing that stopped only
when the appliance was removed); Group 2 = 4
Interventions Comparison: oral appliance versus no treatment
Group 1: oral appliance (personalised acrylic resin oral bite plate for mandibular posi-
tioning)
Group 2: no treatment
Outcomes Reduction of apnoea episodes
Daytime symptoms: sleepiness, irritability, tiredness, school problems, morning
headache, morning thirstiness, oral breathing and nasal stuffiness
Night-time symptoms: habitual snoring, restless sleep and nightmares
Tolerability
Notes We contacted the study author to obtain additional information and althoughwe received
new details, they were not sufficient to clarify our judgements of unclear or high risk of
bias
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quasi-random method of allocation (al-
phabetically by surname)
Allocation concealment (selection bias) High risk Not reported, but due to the poor randomi-
sation method used it could have been im-
possible to make an adequate allocation
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Villa 2002 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk It was impossible to blind the participants
because the intervention group wore an
oral appliance and the control group wore
nothing and could easily be distinguished
from the active intervention; therefore we
assessed the study at high risk of perfor-
mance bias
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk The study lost 5 (26.3%) participants in
the treatment group and 4 (30.8%) in the
control group
Selective reporting (reporting bias) Low risk All outcomes analysed in the results section
were reported under methods
Other bias Unclear risk The study authors did not report any other
interventions during the same treatment
time. The study authors reported that there
were no differences between groups at base-
line but there is no analysis to support this
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ghodke 2014 No sleep assessment
Guilleminault 2011 No placebo or no treatment group
Nunes 2011 Study did not use polysomnography to assess sleep
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D A T A A N D A N A L Y S E S
Comparison 1. Oral appliance versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Apnoea-hypopnoea index
measured by polysomnography
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.39 [0.20, 0.76]
2 Daytime symptoms: Sleepiness
measured by questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.64 [0.11, 3.78]
3 Daytime symptoms: Irritability
measured by questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.07, 1.41]
4 Daytime symptoms: Tiredness
measured by questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.26 [0.06, 1.05]
5 Daytime symptoms: School
problems measured by
questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.64 [0.11, 3.78]
6 Daytime symptoms: Morning
headache measured by
questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.39 [0.12, 1.23]
7 Daytime symptoms: Thirstiness
in the morning measured by
questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.16 [0.02, 1.22]
8 Daytime symptoms: Oral
breathing measured by
questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.16 [0.04, 0.59]
9 Daytime symptoms: Nasal
stuffiness measured by
questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.18 [0.05, 0.69]
10 Night-time symptoms:
Habitual snoring measured by
questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.18 [0.06, 0.55]
11 Night-time symptoms:
Restless sleep measured by
questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.21 [0.05, 0.84]
12 Night-time symptoms:
Nightmares measured by
questionnaire
1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.22 [0.01, 4.93]
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A D D I T I O N A L T A B L E S
Table 1. Apnoea/hypopnoea index - Treated group (from paper)
Index Baseline mean values After 6 months P value (Student t)
Apnoea/hypopnoea index 7.1 +/- 4.6 2.6 +/- 2.2 < 0.001
Values expressed by mean +/- standard deviation. Student t test before versus after therapy.
Table 2. Daytime symptoms - Treated group (from paper)
Symptoms Baseline (n/N) After 6 months (n/N) P value (Pearson X2)
Sleepiness 78.6% (11/14) 14.3% (2/14) 0.002
Irritability 85.7% (12/14) 14.3% (2/14) < 0.001
Tiredness 78.6% (11/14) 14.3% (2/14) 0.002
School problems 35.7% (5/14) 14.3% (2/14) NS
Morning headache 57.1% (8/14) 21.4% (3/14) NS
Thirstiness in the morning 71.4% (10/14) 7.1% (1/14) 0.002
Oral breathing 92.9% (13/14) 14.3% (2/14) < 0.001
Nasal stuffiness 92.9% (13/14) 14.3% (2/14) < 0.001
n = number of children with symptom; N = total number of children; NS = non-significant.
Table 3. Daytime symptoms - Control group (from paper)
Symptoms Baseline (n/N) After 6 months (n/N) P value (Pearson X2)
Sleepiness 33.3% (3/9) 22.2% (2/9) NS
Irritability 44.4% (4/9) 44.4% (4/9) NS
Tiredness 55.6% (5/9) 55.6% (5/9) NS
School problems 22.2% (2/9) 22.2% (2/9) NS
Morning headache 55.6% (5/9) 55.6% (5/9) NS
Thirstiness in the morning 55.6% (5/9) 44.4% (4/9) NS
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Table 3. Daytime symptoms - Control group (from paper) (Continued)
Oral breathing 100% (9/9) 88.9% (8/9) NS
Nasal stuffiness 77.8% (7/9) 77.8% (7/9) NS
n = number of children with symptom; N = total number of children; NS = non-significant.
Table 4. Night-time symptoms - Treated group (from paper)
Symptoms Baseline (n/N) After 6 months (n/N) P value (Pearson X2)
Habitual snoring 92.9% (13/14) 14.3% (2/14) < 0.001
Restless sleep 92.9% (13/14) 14.3% (2/14) < 0.001
Nightmares 28.6% (4/14) 0% (0/14) NS
n = number of children with symptom; N = total number of children; NS = non-significant.
Table 5. Night-time symptoms - Control group (from paper)
Symptoms Baseline (n/N) After 6 months (n/N) P value (Pearson X2)
Habitual snoring 100% (9/9) 100% (9/9) NS
Restless sleep 66.7% (6/9) 66.7% (6/9) NS
Nightmares 11.1% (1/9) 11.1% (1/9) NS
n = number of children with symptom; N = total number of children; NS = non-significant.
WH A T ’ S N E W
Last assessed as up-to-date: 7 April 2016.
Date Event Description
1 November 2016 Review declared as stable This review will not be updated until a substantial body of evidence on the topic
becomes available. If trials are conducted and found eligible for inclusion in the
future, the review would then be updated accordingly
24Oral appliances and functional orthopaedic appliances for obstructive sleep apnoea in children (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
H I S T O R Y
Protocol first published: Issue 4, 2005
Review first published: Issue 2, 2007
Date Event Description
15 September 2016 New citation required but conclusions have not
changed
Two of the original authors not involved in the update.
A new author was added.
Background and methods sections updated. ’Risk of
bias’ assessment completed. ’Summary of findings’ ta-
ble added
7 April 2016 New search has been performed Searches updated to April 2016. No new studies found
for inclusion
1 August 2008 Amended Converted to new review format
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N O T E S
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eligible for inclusion in the future, the review would then be updated accordingly.
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